Select A Location[vc_row][vc_column][vc_column_text]
MycoGard
Mycoplasma hyopneumoniae Bacterin
Product Profile
Safety Data Sheet
Product Description
- Two-dose Mycoplasma hyopneumoniae bacterin for vaccination of
swine - Inactivated bivalent-adjuvanted formulation using StimGard™ adjuvant
- Each vial contains 50 or 250 doses (1 mL/dose)
Key Features
- Pig-proven under field conditions
- Contains StimGard™ bivalent adjuvant
- Proven in millions of vaccinated pigs
- Excellent syringeability
- Advanced purification process allows low-volume injection for
minimal tissue reaction - Cap colored for easy identification
- QR (quick response) codes on the label for inventory and tracking purposes
Label Indications and Dosage
For Swine: Use in healthy piglets of all breeds, 2 weeks of age or older, as an aid in the reduction of lung lesions caused by Mycoplasma hyopneumoniae.
mL of MycoGard® per Injection per Pig
1.0 mL
Withdrawal Period
- 21 days
Packaging
- 50-mL or 250-mL vials.
Formulation
- Inactivated bivalent-adjuvanted formulation using StimGard™ adjuvant.
Swine
For Swine: Use in healthy piglets of all breeds, 2 weeks of age or older, as an aid in the reduction of lung lesions caused by Mycoplasma hyopneumoniae.
mL of MycoGard® per Injection per Pig
1.0 mL
Available in the USA
The labeling contains complete use information, including any cautions and warnings. Always read, understand and follow the labeling and use directions. See the reverse side for use directions and additional information.
Deracin™ 90
(chlortetracycline)
Type A Medicated Feed
VFD Forms
Product Description
- Antibacterial premix of chlortetracycline for oral administration in feed
- Each pound of premix contains 90 Grams of chlortetracycline activity
- Free-flowing meal feed medication for:
- Cattle
- Pneumonia
- Enteritis
- Anaplasmosis
- Liver abscess
- Swine
- Enteritis
- Pneumonia
- Ileitis
- Leptospirosis
- Jowl abscesses
- Chickens
- Synovitis
- Chronic respiratory disease
- Air sac infection
- E. coli
- Turkeys
- Synovitis
- Hexamitiasis
- Paratyphoid
- Bluecomb
- Sheep
- Abortions
- Ducks
- Fowl cholera
- Psittacine birds
- Psittacosis
- Cattle
- 50-lb bag
Key Features
- Generic equivalent (ANADA 200-510) to Aureomycin®
- Broad spectrum, effective against both Gram-positive and Gram-negative organisms
- Readily absorbed, providing effective blood and lung concentrations
- Cattle industry product standard for control of anaplasmosis
- Can be top dressed in cattle feeds
- Can be fed to cattle on pasture with bluebird free choice mineral
- Versatile, wide range of approved combinations including Deccox®, Bovatec®, and Denagard®
- Wide safety margin
- High-quality manufacturing at US Pharmgate facilities according to FDA requirements
Label Indications and Dosage
For Beef Cattle (over 700 lb): For control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline
Use Levels of Chlortetracycline
0.5 mg/lb body weight/day
For Beef and Non-Lactating Dairy Cattle: As an aid in the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline.
For use in free-choice feeds. A medicated feed mill license is required when the free-choice feed is manufactured using a proprietary formula and/or specifications. Free-choice feed formulations must be FDA approved.
Use Levels of Chlortetracycline
0.5-2.0 mg/lb body weight/day
For Calves, Beef, and Non-Lactating Dairy Cattle: For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline.
The appropriate amount of Deracin® containing feed supplement may be mixed in the cattle’s daily ration or administered as a top dress. If the Deracin® containing feed supplement is administered as a top dress, it must be spread uniformly on top of the ration and sufficient space must be provided so that all cattle can eat at the same time.
Use Levels of Chlortetracycline
10 mg/lb body weight/day
Feed for not more than 5 days
Withdrawal Periods and Residue Warnings: No withdrawal period is required when used according to label. This drug is not approved for use in female dairy cattle 20 months of age or older, including dry dairy cows. Use in these cattle may cause drug residues in milk and/or in calves born to these cows. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to be processed for veal.
For Growing Cattle (over 400lb): For the reduction of the incidence of liver abscesses.
Use Levels of Chlortetracycline
70 mg/head/day
For Beef Cattle and Dairy Replacement Heifers: For control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline
Use Levels of Chlortetracycline
350 mg/head/day
For Beef Cattle (under 700 lb): For the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline
Use Levels of Chlortetracycline
350 mg/head/day
Withdrawal Periods and Residue Warnings: No withdrawal period is required when used according to label. This drug is not approved for use in female dairy cattle 20 months of age or older, including dry dairy cows. Use in these cattle may cause drug residues in milk and/or in calves born to these cows. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to be processed for veal.
For Swine: Control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis susceptible to chlortetracycline. Treatment of bacterial enteritis caused be Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline. (Note: This drug level is equivalent to approximately 400 grams per ton, depending on feed consumption and body weight).
Use Levels of Chlortetracycline
10 mg/lb body weight/day
Feed for not more than 14 days
WARNING: ZERO-DAY WITHDRAWAL PERIOD.
For Swine: Reduction in incidence of cervical lymphaderitis (jowl abscesses) caused by Group E. Streptococci susceptible to chlortetracycline
Use Levels of Chlortetracycline
50-100 g per ton in complete feed
For Breeding Swine: Control of leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to chlortetracycline
Use Levels of Chlortetracycline
400 g per ton in complete feed
WARNING: ZERO-DAY WITHDRAWAL PERIOD.
For Chickens: Control of infectious synovitis caused by Mycoplasma synoviae susceptible to chlortetracycline
Use Levels of Chlortetracycline
100-200 g per ton complete feed
Feed continuously for 7 to 14 days
WARNING: ZERO-DAY WITHDRAWAL PERIOD.
For Chickens: Control of chronic respiratory disease (CRD) and air sac infection caused by Mycoplasma gallisepticum and Escherichia coli susceptible to chlortetracycline
Use Levels of Chlortetracycline
200-400 g per ton complete feed
Feed continuously for 7 to 14 days
WARNING: ZERO-DAY WITHDRAWAL PERIOD.
For Chickens: Reduction of mortality due to Escherichia coli infections susceptible to chlortetracycline
Use Levels of Chlortetracycline
500 g per ton complete feed
WARNING: ZERO-DAY WITHDRAWAL PERIOD.
For Chickens: Reduction of mortality due to Escherichia coli infections susceptible to chlortetracycline
Use Levels of Chlortetracycline
500 g per ton complete feed
WARNING: ZERO-DAY WITHDRAWAL PERIOD.
For Turkeys: Control of complicating bacterial organisms associated with bluecomb (transmissible enteritis, coronaviral enteritis) susceptible to chlortetracycline
Use Levels of Chlortetracycline
25mg/lb body weight/day
Feed continuously for 7 to 14 days
WARNING: DO NOT FEED TO DUCKS OR TURKEYS PRODUCING EGGS FOR HUMAN CONSUMPTION
ZERO-DAY WITHDRAWAL PERIOD
For Turkeys: Control of infectious synovitis caused by Mycoplasma synoviae susceptible to chlortetracycline.
Use Levels of Chlortetracycline
200 g per ton complete feed
Feed continuously for 7 to 14 days
For Turkeys: Control of hexamitiasis caused by Hexamita meleagridis susceptible to chlortetracycline
Use Levels of Chlortetracycline
400 g per ton complete feed
Feed continuously for 7 to 14 days
For Turkey poults not over 4 weeks of age: Reduction of mortality due to paratyphoid caused by Salmonella typhimurium susceptible to chlortetracycline
Use Levels of Chlortetracycline
400 g per ton complete feed
WARNING: DO NOT FEED TO DUCKS OR TURKEYS PRODUCING EGGS FOR HUMAN CONSUMPTION
ZERO-DAY WITHDRAWAL PERIOD
For Ducks: Control and treatment of fowl cholera caused by Pasteurella multocida susceptible to chlortetracycline
Use Levels of Chlortetracycline
200-400 g per ton complete feed
Feed in complete ration to provide from 8 to 28 mg per pound of body weight per day depending on age and severity of disease.
Feed for not more than 21 days
WARNING: DO NOT FEED TO DUCKS OR TURKEYS PRODUCING EGGS FOR HUMAN CONSUMPTION
ZERO-DAY WITHDRAWAL PERIOD
For Breeding Sheep: Reduction in the incidence of (vibrionic) abortions caused by Campylobacter fetus infection susceptible to chlortetracycline
Use Levels of Chlortetracycline
80 mg/head/day
WARNING: ZERO-DAY WITHDRAWAL PERIOD
For Psittacine birds: Treatment of psittacine birds (parrots, macaws, cockatoos) suspected or known to be infected with psittacosis caused by Chlamydia psittaci sensitive to chlortetracycline
Use Levels of Chlortetracycline
10 mg per g of complete feed
Feed continuously for 45 days. Each bird should consume an amount of medicated feed equal to one-fifth of this body weight. During treatment, parrots, macaws, and cockatoos should be kept individually or in pairs in clean cages.
WARNING: PSITTACOSIS, AVIAN CHLAMYDIOSIS, OR ORNITHOSIS IS A REPORTABLE COMMUNICABLE DISEASE, TRANSMISSIBLE BETWEEN WILD AND DOMESTIC BIRDS, OTHER ANIMALS AND MAN. CONTACT APPROPRIATE PUBLIC HEALTH AND REGULATORY OFFICIALS.
CAUTION: ASPERGILLOSIS MAY OCCUR FOLLOWING PROLONGED TREATMENT.
Withdrawal Periods and Residue Warnings
No withdrawal period is required when used according to label. This drug is not approved for use in female dairy cattle 20 months of age or older, including dry dairy cows. Use in these cattle may cause drug residues in milk and/or in calves born to these cows. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to be processed for veal. Do not feed to ducks or turkeys producing eggs for human consumption.
Packaging
- 50-lb bag
Formulation
- Free-flowing meal medicated article
- Ingredients: Dried Streptomyces aureofaciens fermentation product in a carrier suitable for incorporation in feed.
FDA Status
- CAUTION: Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
- Type A Medicated Article for use in the manufacture of medicated dry feeds (not for use in liquid feeds).
- Category 1 drug; does not require a feedmill license.
- Approved by FDA under ANADA # 200-510
Cattle
For Beef Cattle (over 700 lb): For control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline
Use Levels of Chlortetracycline
0.5 mg/lb body weight/day
For Beef and Non-Lactating Dairy Cattle: As an aid in the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline
Use Levels of Chlortetracycline
0.5-2.0 mg/lb body weight/day
For Calves, Beef, and Non-Lactating Dairy Cattle: For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline.
Use Levels of Chlortetracycline
10 mg/lb body weight/day
Feed for not more than 5 days
WARNING: A WITHDRAWAL PERIOD HAS NOT BEEN ESTABLISHED FOR THIS PRODUCT IN PRERUMINATING CALVES. DO NOT USE IN CALVES TO BE PROCESSED FOR VEAL.
ZERO-DAY WITHDRAWAL PERIOD.
For Growing Cattle (over 400lb): For the reduction of the incidence of liver abscesses.
Use Levels of Chlortetracycline
70 mg/head/day
For Beef Cattle and Dairy Replacement Heifers: For control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline
Use Levels of Chlortetracycline
350 mg/head/day
For Beef Cattle (under 700 lb): For the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline
Use Levels of Chlortetracycline
350 mg/head/day
WARNING: A WITHDRAWAL PERIOD HAS NOT BEEN ESTABLISHED FOR THIS PRODUCT IN PRERUMINATING CALVES. DO NOT USE IN CALVES TO BE PROCESSED FOR VEAL. ZERO-DAY WITHDRAWAL PERIOD.
Swine
For Swine: Control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis susceptible to chlortetracycline. Treatment of bacterial enteritis caused be Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline. (Note: This drug level is equivalent to approximately 400 grams per ton, depending on feed consumption and body weight).
Use Levels of Chlortetracycline HCl
10 mg/lb body weight/day
Feed for not more than 14 days
WARNING: ZERO-DAY WITHDRAWAL PERIOD.
For Swine: Reduction in incidence of cervical lymphaderitis (jowl abscesses) caused by Group E. Streptococci susceptible to chlortetracycline
Use Levels of Chlortetracycline
50-100 g per ton in complete feed
For Breeding Swine: Control of leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to chlortetracycline
Use Levels of Chlortetracycline
400 g per ton in complete feed
WARNING: ZERO-DAY WITHDRAWAL PERIOD.
Chickens
For Chickens: Control of infectious synovitis caused by Mycoplasma synoviae susceptible to chlortetracycline
Use Levels of Chlortetracycline
100-200 g per ton complete feed
Feed continuously for 7 to 14 days
WARNING: ZERO-DAY WITHDRAWAL PERIOD.
For Chickens: Control of chronic respiratory disease (CRD) and air sac infection caused by Mycoplasma gallisepticum and Escherichia coli susceptible to chlortetracycline
Use Levels of Chlortetracycline
200-400 g per ton complete feed
Feed continuously for 7 to 14 days
WARNING: ZERO-DAY WITHDRAWAL PERIOD.
For Chickens: Reduction of mortality due to Escherichia coli infections susceptible to chlortetracycline
Use Levels of Chlortetracycline
500 g per ton complete feed
WARNING: ZERO-DAY WITHDRAWAL PERIOD.
For Chickens: Reduction of mortality due to Escherichia coli infections susceptible to chlortetracycline
Use Levels of Chlortetracycline
500 g per ton complete feed
WARNING: ZERO-DAY WITHDRAWAL PERIOD.
Turkeys
For Turkeys: Control of complicating bacterial organisms associated with bluecomb (transmissible enteritis, coronaviral enteritis) susceptible to chlortetracycline
Use Levels of Chlortetracycline
25mg/lb body weight/day
Feed continuously for 7 to 14 days
WARNING: DO NOT FEED TO DUCKS OR TURKEYS PRODUCING EGGS FOR HUMAN CONSUMPTION
ZERO-DAY WITHDRAWAL PERIOD
For Turkeys: Control of infectious synovitis caused by Mycoplasma synoviae susceptible to chlortetracycline.
Use Levels of Chlortetracycline
200 g per ton complete feed
Feed continuously for 7 to 14 days
For Turkeys: Control of hexamitiasis caused by Hexamita meleagridis susceptible to chlortetracycline
Use Levels of Chlortetracycline
400 g per ton complete feed
Feed continuously for 7 to 14 days
For Turkey poults not over 4 weeks of age: Reduction of mortality due to paratyphoid caused by Salmonella typhimurium susceptible to chlortetracycline
Use Levels of Chlortetracycline
400 g per ton complete feed
WARNING: Do not feed to ducks or turkeys producing eggs for human consumption
Zero-Day Withdrawal period
Ducks
For Ducks: Control and treatment of fowl cholera caused by Pasteurella multocida susceptible to chlortetracycline
Use Levels of Chlortetracycline
200-400 g per ton complete feed
Feed in complete ration to provide from 8 to 28 mg per pound of body weight per day depending on age and severity of disease.
Feed for not more than 21 days
WARNING: DO NOT FEED TO DUCKS OR TURKEYS PRODUCING EGGS FOR HUMAN CONSUMPTION
ZERO-DAY WITHDRAWAL PERIOD
Sheep
For Breeding Sheep: Reduction in the incidence of (vibrionic) abortions caused by Campylobacter fetus infection susceptible to chlortetracycline
Use Levels of Chlortetracycline
80 mg/head/day
WARNING: ZERO-DAY WITHDRAWAL PERIOD
Psittacine Birds
For Psittacine birds: Treatment of psittacine birds (parrots, macaws, cockatoos) suspected or known to be infected with psittacosis caused by Chlamydia psittaci sensitive to chlortetracycline
Use Levels of Chlortetracycline
10 mg per g of complete feed
Feed continuously for 45 days. Each bird should consume an amount of medicated feed equal to one-fifth of this body weight. During treatment, parrots, macaws, and cockatoos should be kept individually or in pairs in clean cages.
WARNING: PSITTACOSIS, AVIAN CHLAMYDIOSIS, OR ORNITHOSIS IS A REPORTABLE COMMUNICABLE DISEASE, TRANSMISSIBLE BETWEEN WILD AND DOMESTIC BIRDS, OTHER ANIMALS AND MAN. CONTACT APPROPRIATE PUBLIC HEALTH AND REGULATORY OFFICIALS.
CAUTION: ASPERGILLOSIS MAY OCCUR FOLLOWING PROLONGED TREATMENT.
Available in the USA
The labeling contains complete use information, including any cautions and warnings. Always read, understand and follow the labeling and use directions. See the reverse side for use directions and additional information.
Deracin™ 50
(chlortetracycline)
Type A Medicated Feed
VFD Forms
Product Description
- Antibacterial premix of chlortetracycline for oral administration in feed
- Each pound of premix contains 90 Grams of chlortetracycline activity
- Free-flowing meal feed medication for:
- Cattle
- Pneumonia
- Enteritis
- Anaplasmosis
- Liver abscess
- Swine
- Enteritis
- Pneumonia
- Ileitis
- Leptospirosis
- Jowl abscesses
- Chickens
- Synovitis
- Chronic respiratory disease
- Air sac infection
- E. coli
- Turkeys
- Synovitis
- Hexamitiasis
- Paratyphoid
- Bluecomb
- Sheep
- Abortions
- Ducks
- Fowl cholera
- Psittacine birds
- Psittacosis
- Cattle
- 50-lb bag
Key Features
- Generic equivalent (ANADA 200-510) to Aureomycin®
- Broad spectrum, effective against both Gram-positive and Gram-negative organisms
- Readily absorbed, providing effective blood and lung concentrations
- Cattle industry product standard for control of anaplasmosis
- Can be top dressed in cattle feeds
- Can be fed to cattle on pasture with bluebird free choice mineral
- Versatile, wide range of approved combinations including Deccox®, Bovatec®, and Denagard®
- Wide safety margin
- High-quality manufacturing at US Pharmgate facilities according to FDA requirements
Label Indications and Dosage
For Beef Cattle (over 700 lb): For control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline
Use Levels of Chlortetracycline
0.5 mg/lb body weight/day
For Beef and Non-Lactating Dairy Cattle: As an aid in the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline.
For use in free-choice feeds. A medicated feed mill license is required when the freechoice feed is manufactured using a proprietary formula and/or specifications. Freechoice feed formulations must be FDA approved.
Use Levels of Chlortetracycline
0.5-2.0 mg/lb body weight/day
For Calves, Beef, and Non-Lactating Dairy Cattle: For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline.
The appropriate amount of Deracin® containing feed supplement may be mixed in the cattle’s daily ration or administered as a top dress. If the Deracin® containing feed supplement is administered as a top dress, it must be spread uniformly on top of the ration and sufficient space must be provided so that all cattle can eat at the same time.
Use Levels of Chlortetracycline
10 mg/lb body weight/day
Feed for not more than 5 days
Withdrawal Periods and Residue Warnings: No withdrawal period is required when used according to label. This drug is not approved for use in female dairy cattle 20 months of age or older, including dry dairy cows. Use in these cattle may cause drug residues in milk and/or in calves born to these cows. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to be processed for veal.
For Growing Cattle (over 400lb): For the reduction of the incidence of liver abscesses.
Use Levels of Chlortetracycline
70 mg/head/day
For Beef Cattle and Dairy Replacement Heifers: For control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline
Use Levels of Chlortetracycline
350 mg/head/day
For Beef Cattle (under 700 lb): For the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline
Use Levels of Chlortetracycline
350 mg/head/day
Withdrawal Periods and Residue Warnings: No withdrawal period is required when used according to label. This drug is not approved for use in female dairy cattle 20 months of age or older, including dry dairy cows. Use in these cattle may cause drug residues in milk and/or in calves born to these cows. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to be processed for veal.
For Swine: Control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis susceptible to chlortetracycline. Treatment of bacterial enteritis caused be Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline. (Note: This drug level is equivalent to approximately 400 grams per ton, depending on feed consumption and body weight).
Use Levels of Chlortetracycline
10 mg/lb body weight/day
Feed for not more than 14 days
WARNING: ZERO-DAY WITHDRAWAL PERIOD.
For Swine: Reduction in incidence of cervical lymphaderitis (jowl abscesses) caused by Group E. Streptococci susceptible to chlortetracycline
Use Levels of Chlortetracycline
50-100 g per ton in complete feed
For Breeding Swine: Control of leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to chlortetracycline
Use Levels of Chlortetracycline
400 g per ton in complete feed
WARNING: ZERO-DAY WITHDRAWAL PERIOD.
For Chickens: Control of infectious synovitis caused by Mycoplasma synoviae susceptible to chlortetracycline
Use Levels of Chlortetracycline
100-200 g per ton complete feed
Feed continuously for 7 to 14 days
WARNING: ZERO-DAY WITHDRAWAL PERIOD.
For Chickens: Control of chronic respiratory disease (CRD) and air sac infection caused by Mycoplasma gallisepticum and Escherichia coli susceptible to chlortetracycline
Use Levels of Chlortetracycline
200-400 g per ton complete feed
Feed continuously for 7 to 14 days
WARNING: ZERO-DAY WITHDRAWAL PERIOD.
For Chickens: Reduction of mortality due to Escherichia coli infections susceptible to chlortetracycline
Use Levels of Chlortetracycline
500 g per ton complete feed
WARNING: ZERO-DAY WITHDRAWAL PERIOD.
For Chickens: Reduction of mortality due to Escherichia coli infections susceptible to chlortetracycline
Use Levels of Chlortetracycline
500 g per ton complete feed
WARNING: ZERO-DAY WITHDRAWAL PERIOD.
For Turkeys: Control of complicating bacterial organisms associated with bluecomb (transmissible enteritis, coronaviral enteritis) susceptible to chlortetracycline
Use Levels of Chlortetracycline
25mg/lb body weight/day
Feed continuously for 7 to 14 days
WARNING: DO NOT FEED TO DUCKS OR TURKEYS PRODUCING EGGS FOR HUMAN CONSUMPTION
ZERO-DAY WITHDRAWAL PERIOD
For Turkeys: Control of infectious synovitis caused by Mycoplasma synoviae susceptible to chlortetracycline.
Use Levels of Chlortetracycline
200 g per ton complete feed
Feed continuously for 7 to 14 days
For Turkeys: Control of hexamitiasis caused by Hexamita meleagridis susceptible to chlortetracycline
Use Levels of Chlortetracycline
400 g per ton complete feed
Feed continuously for 7 to 14 days
For Turkey poults not over 4 weeks of age: Reduction of mortality due to paratyphoid caused by Salmonella typhimurium susceptible to chlortetracycline
Use Levels of Chlortetracycline
400 g per ton complete feed
WARNING: DO NOT FEED TO DUCKS OR TURKEYS PRODUCING EGGS FOR HUMAN CONSUMPTION
ZERO-DAY WITHDRAWAL PERIOD
For Ducks: Control and treatment of fowl cholera caused by Pasteurella multocida susceptible to chlortetracycline
Use Levels of Chlortetracycline
200-400 g per ton complete feed
Feed in complete ration to provide from 8 to 28 mg per pound of body weight per day depending on age and severity of disease.
Feed for not more than 21 days
WARNING: DO NOT FEED TO DUCKS OR TURKEYS PRODUCING EGGS FOR HUMAN CONSUMPTION
ZERO-DAY WITHDRAWAL PERIOD
For Breeding Sheep: Reduction in the incidence of (vibrionic) abortions caused by Campylobacter fetus infection susceptible to chlortetracycline
Use Levels of Chlortetracycline
80 mg/head/day
WARNING: ZERO-DAY WITHDRAWAL PERIOD
For Psittacine birds: Treatment of psittacine birds (parrots, macaws, cockatoos) suspected or known to be infected with psittacosis caused by Chlamydia psittaci sensitive to chlortetracycline
Use Levels of Chlortetracycline
10 mg per g of complete feed
Feed continuously for 45 days. Each bird should consume an amount of medicated feed equal to one-fifth of this body weight. During treatment, parrots, macaws, and cockatoos should be kept individually or in pairs in clean cages.
WARNING: PSITTACOSIS, AVIAN CHLAMYDIOSIS, OR ORNITHOSIS IS A REPORTABLE COMMUNICABLE DISEASE, TRANSMISSIBLE BETWEEN WILD AND DOMESTIC BIRDS, OTHER ANIMALS AND MAN. CONTACT APPROPRIATE PUBLIC HEALTH AND REGULATORY OFFICIALS.
CAUTION: ASPERGILLOSIS MAY OCCUR FOLLOWING PROLONGED TREATMENT.
Withdrawal Periods and Residue Warnings
No withdrawal period is required when used according to label. This drug is not
approved for use in female dairy cattle 20 months of age or older, including dry dairy
cows. Use in these cattle may cause drug residues in milk and/or in calves born to these
cows. A withdrawal period has not been established for this product in pre-ruminating
calves. Do not use in calves to be processed for veal. Do not feed to ducks or turkeys
producing eggs for human consumption.
Packaging
- 50-lb bag
Formulation
- Free-flowing meal medicated article
- Ingredients: Dried Streptomyces aureofaciens fermentation product in a carrier suitable for incorporation in feed.
FDA Status
- CAUTION: Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
- Type A Medicated Article for use in the manufacture of medicated dry feeds (not for use in liquid feeds).
- Category 1 drug; does not require a feedmill license.
- Approved by FDA under ANADA # 200-510
Cattle
For Beef Cattle (over 700 lb): For control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline
Use Levels of Chlortetracycline
0.5 mg/lb body weight/day
For Beef and Non-Lactating Dairy Cattle: As an aid in the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline
Use Levels of Chlortetracycline
0.5-2.0 mg/lb body weight/day
For Calves, Beef, and Non-Lactating Dairy Cattle: For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline.
Use Levels of Chlortetracycline
10 mg/lb body weight/day
Feed for not more than 5 days
WARNING: A WITHDRAWAL PERIOD HAS NOT BEEN ESTABLISHED FOR THIS PRODUCT IN PRERUMINATING CALVES. DO NOT USE IN CALVES TO BE PROCESSED FOR VEAL.
ZERO-DAY WITHDRAWAL PERIOD.
For Growing Cattle (over 400lb): For the reduction of the incidence of liver abscesses.
Use Levels of Chlortetracycline
70 mg/head/day
For Beef Cattle and Dairy Replacement Heifers: For control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline
Use Levels of Chlortetracycline
350 mg/head/day
For Beef Cattle (under 700 lb): For the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline
Use Levels of Chlortetracycline
350 mg/head/day
WARNING: A WITHDRAWAL PERIOD HAS NOT BEEN ESTABLISHED FOR THIS PRODUCT IN PRERUMINATING CALVES. DO NOT USE IN CALVES TO BE PROCESSED FOR VEAL. ZERO-DAY WITHDRAWAL PERIOD.
Swine
For Swine: Control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis susceptible to chlortetracycline. Treatment of bacterial enteritis caused be Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline. (Note: This drug level is equivalent to approximately 400 grams per ton, depending on feed consumption and body weight).
Use Levels of Chlortetracycline HCl
10 mg/lb body weight/day
Feed for not more than 14 days
WARNING: ZERO-DAY WITHDRAWAL PERIOD.
For Swine: Reduction in incidence of cervical lymphaderitis (jowl abscesses) caused by Group E. Streptococci susceptible to chlortetracycline
Use Levels of Chlortetracycline
50-100 g per ton in complete feed
For Breeding Swine: Control of leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to chlortetracycline
Use Levels of Chlortetracycline
400 g per ton in complete feed
WARNING: ZERO-DAY WITHDRAWAL PERIOD.
Chickens
For Chickens: Control of infectious synovitis caused by Mycoplasma synoviae susceptible to chlortetracycline
Use Levels of Chlortetracycline
100-200 g per ton complete feed
Feed continuously for 7 to 14 days
WARNING: ZERO-DAY WITHDRAWAL PERIOD.
For Chickens: Control of chronic respiratory disease (CRD) and air sac infection caused by Mycoplasma gallisepticum and Escherichia coli susceptible to chlortetracycline
Use Levels of Chlortetracycline
200-400 g per ton complete feed
Feed continuously for 7 to 14 days
WARNING: ZERO-DAY WITHDRAWAL PERIOD.
For Chickens: Reduction of mortality due to Escherichia coli infections susceptible to chlortetracycline
Use Levels of Chlortetracycline
500 g per ton complete feed
WARNING: ZERO-DAY WITHDRAWAL PERIOD.
For Chickens: Reduction of mortality due to Escherichia coli infections susceptible to chlortetracycline
Use Levels of Chlortetracycline
500 g per ton complete feed
WARNING: ZERO-DAY WITHDRAWAL PERIOD.
Turkeys
For Turkeys: Control of complicating bacterial organisms associated with bluecomb (transmissible enteritis, coronaviral enteritis) susceptible to chlortetracycline
Use Levels of Chlortetracycline
25mg/lb body weight/day
Feed continuously for 7 to 14 days
WARNING: DO NOT FEED TO DUCKS OR TURKEYS PRODUCING EGGS FOR HUMAN CONSUMPTION
ZERO-DAY WITHDRAWAL PERIOD
For Turkeys: Control of infectious synovitis caused by Mycoplasma synoviae susceptible to chlortetracycline.
Use Levels of Chlortetracycline
200 g per ton complete feed
Feed continuously for 7 to 14 days
For Turkeys: Control of hexamitiasis caused by Hexamita meleagridis susceptible to chlortetracycline
Use Levels of Chlortetracycline
400 g per ton complete feed
Feed continuously for 7 to 14 days
For Turkey poults not over 4 weeks of age: Reduction of mortality due to paratyphoid caused by Salmonella typhimurium susceptible to chlortetracycline
Use Levels of Chlortetracycline
400 g per ton complete feed
WARNING: Do not feed to ducks or turkeys producing eggs for human consumption
Zero-Day Withdrawal period
Ducks
For Ducks: Control and treatment of fowl cholera caused by Pasteurella multocida susceptible to chlortetracycline
Use Levels of Chlortetracycline
200-400 g per ton complete feed
Feed in complete ration to provide from 8 to 28 mg per pound of body weight per day depending on age and severity of disease.
Feed for not more than 21 days
WARNING: DO NOT FEED TO DUCKS OR TURKEYS PRODUCING EGGS FOR HUMAN CONSUMPTION
ZERO-DAY WITHDRAWAL PERIOD
Sheep
For Breeding Sheep: Reduction in the incidence of (vibrionic) abortions caused by Campylobacter fetus infection susceptible to chlortetracycline
Use Levels of Chlortetracycline
80 mg/head/day
WARNING: ZERO-DAY WITHDRAWAL PERIOD
Psittacine Birds
For Psittacine birds: Treatment of psittacine birds (parrots, macaws, cockatoos) suspected or known to be infected with psittacosis caused by Chlamydia psittaci sensitive to chlortetracycline
Use Levels of Chlortetracycline
10 mg per g of complete feed
Feed continuously for 45 days. Each bird should consume an amount of medicated feed equal to one-fifth of this body weight. During treatment, parrots, macaws, and cockatoos should be kept individually or in pairs in clean cages.
WARNING: PSITTACOSIS, AVIAN CHLAMYDIOSIS, OR ORNITHOSIS IS A REPORTABLE COMMUNICABLE DISEASE, TRANSMISSIBLE BETWEEN WILD AND DOMESTIC BIRDS, OTHER ANIMALS AND MAN. CONTACT APPROPRIATE PUBLIC HEALTH AND REGULATORY OFFICIALS.
CAUTION: ASPERGILLOSIS MAY OCCUR FOLLOWING PROLONGED TREATMENT.
Cattle Swine Breeding Swine Chicken Turkey Sheep Psittacine Birds Swine combination with Denagard Cattle combination with Deccox Cattle combination with Bovatec 
Available in the USA
The labeling contains complete use information, including any cautions and warnings. Always read, understand and follow the labeling and use directions. See the reverse side for use directions and additional information.
Deracin™ 100
(chlortetracycline)
Type A Medicated Feed
VFD Forms
Product Description
- Antibacterial premix of chlortetracycline for oral administration in feed
- Each pound of premix contains 90 Grams of chlortetracycline activity
- Free-flowing meal feed medication for:
- Cattle
- Pneumonia
- Enteritis
- Anaplasmosis
- Liver abscess
- Swine
- Enteritis
- Pneumonia
- Ileitis
- Leptospirosis
- Jowl abscesses
- Chickens
- Synovitis
- Chronic respiratory disease
- Air sac infection
- E. coli
- Turkeys
- Synovitis
- Hexamitiasis
- Paratyphoid
- Bluecomb
- Sheep
- Abortions
- Ducks
- Fowl cholera
- Psittacine birds
- Psittacosis
- Cattle
- 50-lb bag
Key Features
- Generic equivalent (ANADA 200-510) to Aureomycin®
- Broad spectrum, effective against both Gram-positive and Gram-negative organisms
- Readily absorbed, providing effective blood and lung concentrations
- Cattle industry product standard for control of anaplasmosis
- Can be top dressed in cattle feeds
- Can be fed to cattle on pasture with bluebird free choice mineral
- Versatile, wide range of approved combinations including Deccox®, Bovatec®, and Denagard®
- Wide safety margin
- High-quality manufacturing at US Pharmgate facilities according to FDA requirements
Label Indications and Dosage
For Beef Cattle (over 700 lb): For control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline
Use Levels of Chlortetracycline
0.5 mg/lb body weight/day
For Beef and Non-Lactating Dairy Cattle: As an aid in the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline.
For use in free-choice feeds. A medicated feed mill license is required when the freechoice feed is manufactured using a proprietary formula and/or specifications. Freechoice feed formulations must be FDA approved.
Use Levels of Chlortetracycline
0.5-2.0 mg/lb body weight/day
For Calves, Beef, and Non-Lactating Dairy Cattle: For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline.
The appropriate amount of Deracin® containing feed supplement may be mixed in the cattle’s daily ration or administered as a top dress. If the Deracin® containing feed supplement is administered as a top dress, it must be spread uniformly on top of the ration and sufficient space must be provided so that all cattle can eat at the same time.
Use Levels of Chlortetracycline
10 mg/lb body weight/day
Feed for not more than 5 days
Withdrawal Periods and Residue Warnings: No withdrawal period is required when used according to label. This drug is not approved for use in female dairy cattle 20 months of age or older, including dry dairy cows. Use in these cattle may cause drug residues in milk and/or in calves born to these cows. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to be processed for veal.
For Growing Cattle (over 400lb): For the reduction of the incidence of liver abscesses.
Use Levels of Chlortetracycline
70 mg/head/day
For Beef Cattle and Dairy Replacement Heifers: For control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline
Use Levels of Chlortetracycline
350 mg/head/day
For Beef Cattle (under 700 lb): For the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline
Use Levels of Chlortetracycline
350 mg/head/day
Withdrawal Periods and Residue Warnings: No withdrawal period is required when used according to label. This drug is not approved for use in female dairy cattle 20 months of age or older, including dry dairy cows. Use in these cattle may cause drug residues in milk and/or in calves born to these cows. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to be processed for veal.
For Swine: Control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis susceptible to chlortetracycline. Treatment of bacterial enteritis caused be Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline. (Note: This drug level is equivalent to approximately 400 grams per ton, depending on feed consumption and body weight).
Use Levels of Chlortetracycline
10 mg/lb body weight/day
Feed for not more than 14 days
WARNING: ZERO-DAY WITHDRAWAL PERIOD.
For Swine: Reduction in incidence of cervical lymphaderitis (jowl abscesses) caused by Group E. Streptococci susceptible to chlortetracycline
Use Levels of Chlortetracycline
50-100 g per ton in complete feed
For Breeding Swine: Control of leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to chlortetracycline
Use Levels of Chlortetracycline
400 g per ton in complete feed
WARNING: ZERO-DAY WITHDRAWAL PERIOD.
For Chickens: Control of infectious synovitis caused by Mycoplasma synoviae susceptible to chlortetracycline
Use Levels of Chlortetracycline
100-200 g per ton complete feed
Feed continuously for 7 to 14 days
WARNING: ZERO-DAY WITHDRAWAL PERIOD.
For Chickens: Control of chronic respiratory disease (CRD) and air sac infection caused by Mycoplasma gallisepticum and Escherichia coli susceptible to chlortetracycline
Use Levels of Chlortetracycline
200-400 g per ton complete feed
Feed continuously for 7 to 14 days
WARNING: ZERO-DAY WITHDRAWAL PERIOD.
For Chickens: Reduction of mortality due to Escherichia coli infections susceptible to chlortetracycline
Use Levels of Chlortetracycline
500 g per ton complete feed
WARNING: ZERO-DAY WITHDRAWAL PERIOD.
For Chickens: Reduction of mortality due to Escherichia coli infections susceptible to chlortetracycline
Use Levels of Chlortetracycline
500 g per ton complete feed
WARNING: ZERO-DAY WITHDRAWAL PERIOD.
For Turkeys: Control of complicating bacterial organisms associated with bluecomb (transmissible enteritis, coronaviral enteritis) susceptible to chlortetracycline
Use Levels of Chlortetracycline
25mg/lb body weight/day
Feed continuously for 7 to 14 days
WARNING: DO NOT FEED TO DUCKS OR TURKEYS PRODUCING EGGS FOR HUMAN CONSUMPTION
ZERO-DAY WITHDRAWAL PERIOD
For Turkeys: Control of infectious synovitis caused by Mycoplasma synoviae susceptible to chlortetracycline.
Use Levels of Chlortetracycline
200 g per ton complete feed
Feed continuously for 7 to 14 days
For Turkeys: Control of hexamitiasis caused by Hexamita meleagridis susceptible to chlortetracycline
Use Levels of Chlortetracycline
400 g per ton complete feed
Feed continuously for 7 to 14 days
For Turkey poults not over 4 weeks of age: Reduction of mortality due to paratyphoid caused by Salmonella typhimurium susceptible to chlortetracycline
Use Levels of Chlortetracycline
400 g per ton complete feed
WARNING: DO NOT FEED TO DUCKS OR TURKEYS PRODUCING EGGS FOR HUMAN CONSUMPTION
ZERO-DAY WITHDRAWAL PERIOD
For Ducks: Control and treatment of fowl cholera caused by Pasteurella multocida susceptible to chlortetracycline
Use Levels of Chlortetracycline
200-400 g per ton complete feed
Feed in complete ration to provide from 8 to 28 mg per pound of body weight per day depending on age and severity of disease.
Feed for not more than 21 days
WARNING: DO NOT FEED TO DUCKS OR TURKEYS PRODUCING EGGS FOR HUMAN CONSUMPTION
ZERO-DAY WITHDRAWAL PERIOD
For Breeding Sheep: Reduction in the incidence of (vibrionic) abortions caused by Campylobacter fetus infection susceptible to chlortetracycline
Use Levels of Chlortetracycline
80 mg/head/day
WARNING: ZERO-DAY WITHDRAWAL PERIOD
For Psittacine birds: Treatment of psittacine birds (parrots, macaws, cockatoos) suspected or known to be infected with psittacosis caused by Chlamydia psittaci sensitive to chlortetracycline
Use Levels of Chlortetracycline
10 mg per g of complete feed
Feed continuously for 45 days. Each bird should consume an amount of medicated feed equal to one-fifth of this body weight. During treatment, parrots, macaws, and cockatoos should be kept individually or in pairs in clean cages.
WARNING: PSITTACOSIS, AVIAN CHLAMYDIOSIS, OR ORNITHOSIS IS A REPORTABLE COMMUNICABLE DISEASE, TRANSMISSIBLE BETWEEN WILD AND DOMESTIC BIRDS, OTHER ANIMALS AND MAN. CONTACT APPROPRIATE PUBLIC HEALTH AND REGULATORY OFFICIALS.
CAUTION: ASPERGILLOSIS MAY OCCUR FOLLOWING PROLONGED TREATMENT.
Withdrawal Periods and Residue Warnings
No withdrawal period is required when used according to label. This drug is not approved for use in female dairy cattle 20 months of age or older, including dry dairy cows. Use in these cattle may cause drug residues in milk and/or in calves born to these cows. A withdrawal period has not been established for this product in pre-ruminating calves. Do not use in calves to be processed for veal. Do not feed to ducks or turkeys producing eggs for human consumption.
Packaging
- 50-lb bag
Formulation
- Free-flowing meal medicated article
- Ingredients: Dried Streptomyces aureofaciens fermentation product in a carrier suitable for incorporation in feed.
FDA Status
- CAUTION: Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
- Type A Medicated Article for use in the manufacture of medicated dry feeds (not for use in liquid feeds).
- Category 1 drug; does not require a feedmill license.
- Approved by FDA under ANADA # 200-510.
Cattle
For Beef Cattle (over 700 lb): For control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline
Use Levels of Chlortetracycline
0.5 mg/lb body weight/day
For Beef and Non-Lactating Dairy Cattle: As an aid in the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline
Use Levels of Chlortetracycline
0.5-2.0 mg/lb body weight/day
For Calves, Beef, and Non-Lactating Dairy Cattle: For treatment of bacterial enteritis caused by Escherichia coli and bacterial pneumonia caused by Pasteurella multocida organisms susceptible to chlortetracycline.
Use Levels of Chlortetracycline
10 mg/lb body weight/day
Feed for not more than 5 days
WARNING: A WITHDRAWAL PERIOD HAS NOT BEEN ESTABLISHED FOR THIS PRODUCT IN PRERUMINATING CALVES. DO NOT USE IN CALVES TO BE PROCESSED FOR VEAL.
ZERO-DAY WITHDRAWAL PERIOD.
For Growing Cattle (over 400lb): For the reduction of the incidence of liver abscesses.
Use Levels of Chlortetracycline
70 mg/head/day
For Beef Cattle and Dairy Replacement Heifers: For control of bacterial pneumonia associated with shipping fever complex caused by Pasteurella spp. susceptible to chlortetracycline
Use Levels of Chlortetracycline
350 mg/head/day
For Beef Cattle (under 700 lb): For the control of active infection of anaplasmosis caused by Anaplasma marginale susceptible to chlortetracycline
Use Levels of Chlortetracycline
350 mg/head/day
WARNING: A WITHDRAWAL PERIOD HAS NOT BEEN ESTABLISHED FOR THIS PRODUCT IN PRERUMINATING CALVES. DO NOT USE IN CALVES TO BE PROCESSED FOR VEAL. ZERO-DAY WITHDRAWAL PERIOD.
Swine
For Swine: Control of porcine proliferative enteropathies (ileitis) caused by Lawsonia intracellularis susceptible to chlortetracycline. Treatment of bacterial enteritis caused be Escherichia coli and Salmonella choleraesuis and bacterial pneumonia caused by Pasteurella multocida susceptible to chlortetracycline. (Note: This drug level is equivalent to approximately 400 grams per ton, depending on feed consumption and body weight).
Use Levels of Chlortetracycline HCl
10 mg/lb body weight/day
Feed for not more than 14 days
WARNING: ZERO-DAY WITHDRAWAL PERIOD.
For Swine: Reduction in incidence of cervical lymphaderitis (jowl abscesses) caused by Group E. Streptococci susceptible to chlortetracycline
Use Levels of Chlortetracycline
50-100 g per ton in complete feed
For Breeding Swine: Control of leptospirosis (reducing the incidence of abortion and shedding of leptospirae) caused by Leptospira pomona susceptible to chlortetracycline
Use Levels of Chlortetracycline
400 g per ton in complete feed
WARNING: ZERO-DAY WITHDRAWAL PERIOD.
Chickens
For Chickens: Control of infectious synovitis caused by Mycoplasma synoviae susceptible to chlortetracycline
Use Levels of Chlortetracycline
100-200 g per ton complete feed
Feed continuously for 7 to 14 days
WARNING: ZERO-DAY WITHDRAWAL PERIOD.
For Chickens: Control of chronic respiratory disease (CRD) and air sac infection caused by Mycoplasma gallisepticum and Escherichia coli susceptible to chlortetracycline
Use Levels of Chlortetracycline
200-400 g per ton complete feed
Feed continuously for 7 to 14 days
WARNING: ZERO-DAY WITHDRAWAL PERIOD.
For Chickens: Reduction of mortality due to Escherichia coli infections susceptible to chlortetracycline
Use Levels of Chlortetracycline
500 g per ton complete feed
WARNING: ZERO-DAY WITHDRAWAL PERIOD.
For Chickens: Reduction of mortality due to Escherichia coli infections susceptible to chlortetracycline
Use Levels of Chlortetracycline
500 g per ton complete feed
WARNING: ZERO-DAY WITHDRAWAL PERIOD.
Turkeys
For Turkeys: Control of complicating bacterial organisms associated with bluecomb (transmissible enteritis, coronaviral enteritis) susceptible to chlortetracycline
Use Levels of Chlortetracycline
25mg/lb body weight/day
Feed continuously for 7 to 14 days
WARNING: DO NOT FEED TO DUCKS OR TURKEYS PRODUCING EGGS FOR HUMAN CONSUMPTION
ZERO-DAY WITHDRAWAL PERIOD
For Turkeys: Control of infectious synovitis caused by Mycoplasma synoviae susceptible to chlortetracycline.
Use Levels of Chlortetracycline
200 g per ton complete feed
Feed continuously for 7 to 14 days
For Turkeys: Control of hexamitiasis caused by Hexamita meleagridis susceptible to chlortetracycline
Use Levels of Chlortetracycline
400 g per ton complete feed
Feed continuously for 7 to 14 days
For Turkey poults not over 4 weeks of age: Reduction of mortality due to paratyphoid caused by Salmonella typhimurium susceptible to chlortetracycline
Use Levels of Chlortetracycline
400 g per ton complete feed
WARNING: Do not feed to ducks or turkeys producing eggs for human consumption
Zero-Day Withdrawal period
Ducks
For Ducks: Control and treatment of fowl cholera caused by Pasteurella multocida susceptible to chlortetracycline
Use Levels of Chlortetracycline
200-400 g per ton complete feed
Feed in complete ration to provide from 8 to 28 mg per pound of body weight per day depending on age and severity of disease.
Feed for not more than 21 days
WARNING: DO NOT FEED TO DUCKS OR TURKEYS PRODUCING EGGS FOR HUMAN CONSUMPTION
ZERO-DAY WITHDRAWAL PERIOD
Sheep
For Breeding Sheep: Reduction in the incidence of (vibrionic) abortions caused by Campylobacter fetus infection susceptible to chlortetracycline
Use Levels of Chlortetracycline
80 mg/head/day
WARNING: ZERO-DAY WITHDRAWAL PERIOD
Psittacine Birds
For Psittacine birds: Treatment of psittacine birds (parrots, macaws, cockatoos) suspected or known to be infected with psittacosis caused by Chlamydia psittaci sensitive to chlortetracycline
Use Levels of Chlortetracycline
10 mg per g of complete feed
Feed continuously for 45 days. Each bird should consume an amount of medicated feed equal to one-fifth of this body weight. During treatment, parrots, macaws, and cockatoos should be kept individually or in pairs in clean cages.
WARNING: PSITTACOSIS, AVIAN CHLAMYDIOSIS, OR ORNITHOSIS IS A REPORTABLE COMMUNICABLE DISEASE, TRANSMISSIBLE BETWEEN WILD AND DOMESTIC BIRDS, OTHER ANIMALS AND MAN. CONTACT APPROPRIATE PUBLIC HEALTH AND REGULATORY OFFICIALS.
CAUTION: ASPERGILLOSIS MAY OCCUR FOLLOWING PROLONGED TREATMENT.
Available in the USA
The labeling contains complete use information, including any cautions and warnings. Always read, understand and follow the labeling and use directions. See the reverse side for use directions and additional information.
CircoGard
Porcine Circovirus Vaccine,
Type 2, Killed Baculovirus Vector
Product Profile
Safety Data Sheet
Product Description
- One-dose porcine circovirus (PCV) Type 2b vaccine for vaccination of
swine - Inactivated trivalent-adjuvanted formulation using StimGard Plus™
adjuvant - Each vial contains 50 or 250 doses (1 mL/dose)
Key Features
- Pig-proven under field conditions
- StimGard Plus™ trivalent adjuvant system helps optimize both
cell-mediated and humoral immune responses - Safe
- Excellent syringeability
- Advanced purification process allows low-volume injection for
minimal tissue reaction - QR (quick response) codes on the label for inventory and tracking purposes
Label Indications and Dosage
For Swine: Use in healthy piglets of all breeds, 10 days of age or older, against Porcine Circovirus, Type 2.
mL of CircoGard® per Injection per Pig
1.0 mL
Withdrawal Period
- 21 days
Packaging
- 50-mL or 250-mL vials.
Formulation
- Inactivated trivalent-adjuvanted formulation using StimGard Plus™
adjuvant.
Swine
For Swine: Use in healthy piglets of all breeds, 10 days of age or older, against Porcine Circovirus, Type 2.
mL of CircoGard® per Injection per Pig
1.0 mL
Available in the USA
The labeling contains complete use information, including any cautions and warnings. Always read, understand and follow the labeling and use directions. See the reverse side for use directions and additional information.
Circo/MycoGard
Porcine Circovirus Vaccine,
Type 2, Killed Baculovirus Vector,
Mycoplasma hyopneumoniae Bacterin
Product Profile
Safety Data Sheet
Product Description
- One-dose combination of porcine circovirus (PCV) Type 2b vaccine and Mycoplasma hyopneumoniae bacterin for vaccination of swine
- Inactivated trivalent-adjuvanted formulation using StimGard Plus™ adjuvant
- Each vial contains 50 or 250 doses (1 mL/dose)
Key Features
- Pig-proven under field conditions
- StimGard Plus™ trivalent adjuvant system helps optimize both
cell-mediated and humoral immune responses - Safe; studies show a <0.3% reaction rate
- Excellent syringeability
- Advanced purification process allows low-volume injection for minimal tissue reaction
- No mixing means less handling, mistakes and mess
- QR (quick response) codes on the label for inventory and tracking purposes
Label Indications and Dosage
For Swine: Use in healthy piglets of all breeds, 10 days of age or older, against Porcine Circovirus, Type 2, and Mycoplasma hyopneumoniae.
mL. of Circo/MycoGard per Injection per Pig
1.0 mL
Withdrawal Period
- 21 days.
Packaging
- 50-mL or 250-mL vials.
Formulation
- Inactivated trivalent-adjuvanted formulation using StimGard Plus™ adjuvant.
Swine
For Swine: Use in healthy piglets of all breeds, 10 days of age or older, against Porcine Circovirus, Type 2, and Mycoplasma hyopneumoniae.
mL. of Circo/MycoGard per Injection per Pig
1.0 mL
Available in the USA
The labeling contains complete use information, including any cautions and warnings. Always read, understand and follow the labeling and use directions. See the reverse side for use directions and additional information.
AIVLOSIN®
(62.5% w/w Tylvalosin as Tylvalosin Tartrate)
Water Soluble Granules
Product Profile
Mixing Poster
Safety Data Sheet
Product Label
Product Description
- Water-soluble antibiotic for oral use by administration in drinking water for the control of ileitis and respiratory disease in swine
- Contains 62.5% w/w tylvalosin (as tylvalosin tartrate), a broad-spectrum macrolide
- CAUTION: Federal law restricts this drug to use by or on the order of a licensed veterinarian
Key Features
- Quick-acting, potent macrolide antibiotic that is not used in human health.
- Broadest label indication for SRD control now that it is approved to control Mycoplasma hyopneumoniae.
- Accumulates rapidly in lung and small intestinal tissue after treatment.
- Enters into white blood cells within two hours (in vitro).
- No withdrawal period (0 days).
- Wide safety margin; compatible when treating pigs with ionophores.
- Palatable, non-clogging formulation.
- Supports responsible use of antibiotics through fewer milligrams of antibiotic per use per pig.
Label Indications and Dosage
Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Product Description:
Aivlosin® (tylvalosin tartrate) Water Soluble Granules is a water-soluble granular powder for oral use by administration in the drinking water. Each gram of Aivlosin® Water Soluble Granules contains 0.625 grams of tylvalosin as Tylvalosin tartrate.
Antibiotic Classification: Tylvalosin, the active ingredient in Aivlosin® Water Soluble Granules, is a macrolide antibiotic.
Indications:
For Swine:
Control of porcine proliferative enteropathy (PPE) associated with Lawsonia intracellularis infection in groups of swine intended for slaughter and female swine intended for breeding in buildings experiencing an outbreak of PPE. Not for use in male swine intended for breeding.
Control of swine respiratory disease (SRD) associated with Bordetella bronchiseptica, Haemophilus parasuis, Pasteurella multocida, Streptococcus suis, and Mycoplasma hyopneumoniae in groups of swine intended for slaughter and female swine intended for breeding in buildings experiencing an outbreak of SRD. Not for use in male swine intended for breeding.
Dosage and Administration:
Prepare drinking water medicated with 50 parts per million tylvalosin as shown in the following table.
|
Aivlosin® Water Soluble Granules sachet size |
160 grams |
400 grams |
|
Tylvalosin content of sachet (grams) |
100 |
250 |
|
Recommended volume of stock solution (US gallons) |
4 |
10 |
|
Volume of drinking water (US gallons) |
528 |
1320 |
|
Final Tylvalosin inclusion rate in drinking water |
50 parts per million (ppm) |
|
Administer continuously in drinking water for five (5) consecutive days.
Keep water supply equipment clean and in good operating condition. Clean water medication equipment before and after each use. Do not mix or administer tylvalosin medicated water using equipment made of galvanized metal. Galvanized metal adversely affects the stability of tylvalosin in water and may reduce the effectiveness of the product. Prepare a fresh batch of medicated stock solution or medicated drinking water daily.
MIXING DIRECTIONS:
Aivlosin® Water Soluble Granules may be mixed directly into the drinking water system or first mixed as a stock solution in a smaller amount of water, which is then added to the drinking water system, for example, using an automatic water proportioner.
Direct Mixing: When mixing the product directly into the drinking water system, the contents of the sachet should be sprinkled onto the surface of the water and mixed slowly and thoroughly for at least 3 minutes. Prepare a fresh batch of medicated drinking water daily.
Stock Solution:
When preparing a stock solution, the recommended concentration is one 160 g sachet per four (4) US gallons or one 400 g sachet per 10 US gallons. Sprinkle sachet contents onto the surface of the water of the stock solution and mix slowly and thoroughly for at least 10 minutes.
Use the stock solution for dilution into the drinking water system as soon as it is prepared. Add one (1) fluid ounce of this stock solution per 131 fluid ounces (1 US gallon, 3 fluid ounces) of drinking water to provide a final concentration of 50 ppm. If using an automatic water proportioner, set the flow rate to add stock solution at a rate of 1 fluid ounce per 131 fluid ounces of drinking water (1:131). Prepare a fresh batch of medicated stock solution daily.
Antibacterial Warnings: Use of antibacterial drugs in the absence of a susceptible bacterial infection is unlikely to provide benefit to treated animals and may increase the development of drug-resistant pathogenic bacteria.
User Safety Warnings:
NOT FOR USE IN HUMANS.
KEEP OUT OF REACH OF CHILDREN.
May cause skin irritation. Tylvalosin tartrate has been shown to cause hypersensitivity reactions in laboratory animals.
People with known hypersensitivity to tylvalosin tartrate should avoid contact with this product. In case of accidental ingestion, seek medical advice.
When handling Aivlosin® Water Soluble Granules and preparing medicated drinking water, avoid direct contact with the eyes and skin. Wear a dust mask, coveralls and impervious gloves when mixing and handling this product. Eye protection is recommended. In case of accidental eye exposure, wash eyes immediately with water and seek medical attention. If wearing contact lenses, immediately rinse the eyes first, then remove contact lenses and continue to rinse the eyes thoroughly and seek medical attention. Avoid eating, chewing gum and smoking during handling. Wash contaminated skin.
The Safety Data Sheet contains more detailed occupational safety information.
To report adverse effects in users, to obtain more information or obtain a Safety Data Sheet, call Pharmgate Animal Health LLC. at 1-833-531-0114.
Precautions: Not for use in males intended for breeding. The effects of tylvalosin on male swine reproductive performance have not been determined. Sows may exhibit decreased water consumption at the start of treatment. Ensure animals consume adequate amounts of water. The safety and efficacy of this formulation in species other than swine have not been determined.
To assure both food safety and responsible use in swine, concurrent use of tylvalosin in medicated drinking water and tylvalosin or another macrolide in medicated feed or by any other route of administration should be avoided. Tylvalosin belongs to the macrolide antimicrobial drug class. Macrolides are ranked as a critically important drug in human medicine; therefore, minimizing the risk of development of antimicrobial resistance to this class of drug is very important. The following conditions of use and restrictions listed below are critical for the FDA’s strategy of risk management associated with tylvalosin: Always treat the fewest number of animals necessary to control a respiratory disease or PPE outbreak.
Do not immediately follow this macrolide treatment with another macrolide treatment via any route.
Prescriptions should not be renewed or refilled for animals already treated with one course of therapy with tylvalosin as directed (See Dosage and Administration above).
Adverse Reactions in Animals: No adverse reactions related to the drug were observed during clinical or target animal safety trials.
To report suspected adverse reactions in animals, contact Pharmgate Animal Health LLC. at 1-833-531-0114. For additional information about adverse drug experience reporting for animal drugs, contact FDA at 1-888-FDA-VETS or at www.fda.gov/reportanimalae.
CLINICAL PHARMACOLOGY:
Tylvalosin is a 16-membered semi-synthetic macrolide antibiotic. Macrolides are generally considered to be bacteriostatic agents that exert their antibiotic effect by reversibly binding to the 23S rRNA of the 50S ribosomal subunit, thereby inhibiting bacterial protein synthesis. The spectrum of activity of most available macrolides used in veterinary medicine is primarily against Gram-positive bacteria and Mycoplasmas, with some activity against Gram-negative fastidious bacteria. These compounds have no activity against the naturally resistant Enterobacteriaceae, including Escherichia coli and Salmonella spp. Typically, macrolides achieve higher concentrations in tissues than in plasma.
Effectiveness:
Swine:
Control of Porcine Proliferative Enteropathy (PPE): A multi-location challenge model study was conducted to confirm the effectiveness of Aivlosin® Water Soluble Granules for the control of PPE associated with Lawsonia intracellularis.
Pigs were challenged by intragastric gavage with a mucosal homogenate containing a North American isolate of Lawsonia intracellularis isolated in 2005 that induces representative disease in challenged pigs. When at least 15% of the study pigs were showing signs of infection based on abnormal fecal scores, pigs were provided water containing tylvalosin at an inclusion rate of 50 ppm for five consecutive days, or were provided non-medicated water. Effectiveness was evaluated using clinical scores (pig demeanor score, abdominal appearance score, and fecal score) and clinically-validated gross PPE lesion scores. A conclusion of the effectiveness of 50 ppm tylvalosin for the control of PPE was determined based on a statistically significant (p = 0.0103) improvement in the clinically-validated gross PPE lesion scores in the 50 ppm tylvalosin-treated group compared to the non-medicated group.
Control of Swine Respiratory Disease (SRD): The effectiveness of Aivlosin® Water Soluble Granules for the control of swine respiratory disease (SRD) associated with Bordetella bronchiseptica, Haemophilus parasuis, Pasteurella multocida, Streptococcus suis and Mycoplasma hyopneumoniae was investigated in a natural field infection study conducted in the United States (three study sites) and Canada (one study site). Day 0 was defined when at least 15% of the candidate pigs were deemed clinically affected with SRD (moderate or severe respiratory score, moderate or severe depression score, and rectal temperature greater than or equal to 104.0 °F). On Day 0 a total of 980 pigs were enrolled and randomly assigned to a tylvalosin-treated group (50 ppm tylvalosin in drinking water for 5 consecutive days) or a non-medicated control group. Treatment success was evaluated on Day 7 and was defined as a pig with normal or mild respiratory score, normal or mild depression score, and rectal temperature less than 104.0 °F. The proportion of pigs meeting the definition of treatment success was numerically higher in the tylvalosin-treated group (48.5%) compared to the proportion of pigs meeting the definition of treatment success in the non-medicated control group (41.6%), and the observed difference was statistically significant (p=0.0353).
Additional data to demonstrate the effectiveness of Aivlosin® Water Soluble Granules for the control of SRD associated with Mycoplasma hyopneumoniae was obtained in an experimentally-induced infection model study. Two hundred and forty (240) commercial crossbred pigs were challenged endotracheally with a representative isolate of M. hyopneumoniae. One hundred and ninety-two (192) study pigs were randomly assigned to either a tylvalosin-treated group (50 ppm tylvalosin in drinking water for 5 consecutive days) or a nonmedicated control group. Treatment was started when at least four of eight randomly pre-selected sentinel pigs exhibited a minimum of 3% weighted gross lung lesions consistent with M. hyopneumoniae infection. After a 5-day treatment period and a 5-day post-treatment period, study pigs were euthanized and necropsy performed to determine lung lesion scores. The analysis included 95 tylvalosin-treated pigs and 93 nonmedicated control pigs. There was a statistically significant (P<0.0001) improvement in pen mean M. hyopneumoniae lung lesion scores in the 50 ppm Tylvalosin treated pigs (5.1%) compared to negative control (10.9%).
Animal Safety:
Swine:
Margin of safety: Aivlosin® Water Soluble Granules given orally in drinking water at 0, 50, 150 and 250 ppm tylvalosin (0, 1X, 3X and 5X the labeled dose, respectively) to 8 healthy pigs per treatment group over 15 days (3X the labeled duration) did not result in drug-induced clinical signs, gross pathologic lesions, histopathologic lesions or clinically-relevant clinical pathology abnormalities.
Sow Reproductive Safety: A reproductive safety study was conducted to evaluate the effect of Aivlosin® Water Soluble Granules administered to reproducing sows in drinking water. Fourteen multiparous sows (parity 2 to 9; average 4.6) were administered tylvalosin at a targeted inclusion rate of 150 ppm (3X the labeled inclusion rate) in drinking water. Medicated water was supplied ad libitum through a minimum of two estrous cycles, breeding, gestation, farrowing, lactation, and weaning (174 to 195 days total, depending on farrowing date). Piglets were weaned at 21 days post-farrowing. Fourteen multiparous sows (parity 2 to 9; average 3.7) were included in a non-treated control group. Conception rate, farrowing rate, total number of piglets born per sow, total number of piglets born alive per sow, percentage of mummified piglets, percentage of stillbornpiglets, sex ratio, 1-day survival rate, 5-day survival rate, 21-day survival rate (weaning index), average live piglet weight per litter, and sow health were evaluated. Piglets were assessed for congenital abnormalities, body weight, and general health until weaning (21 days post-farrowing). Treatment with tylvalosin had no adverse effect on the evaluated variables (values reported are medians unless otherwise noted). There were no statistically significant differences in total number of piglets born per sow (control group: 24.0; treated group: 21.0), percentage of mummified piglets (control group: 0%, range 0-14.8%; treated group: 0%, range 0-9.1%), or percentage of stillborn piglets (control group: 7.0%, range 0-37.5%; treated group: 10.5%, range 0-35.7%). At a significance level of 0.10, the total number piglets born alive per sow was statistically different between the control group (20.0) and the treated group (16.0). However, the proportion of piglets born alive was not significantly different between the control group (89.2%) and the treated group (85.7%). Sows treated with tylvalosin had reduced water intake at the start of treatment. One sow refused to drink the tylvalosin treated water, became dehydrated, and was removed from the study. Otherwise, no negative health effects due to the transient reduction in water consumption were observed. There were no congenital abnormalities in piglets attributed to tylvalosin. Piglet body weights, survival rates, and general health were consistent with values reported in literature and indicated that tylvalosin did not have a negative effect on piglet growth or viability. The difference in sex ratio between groups was not clinically significant
Withdrawal Period
- When used in accordance with label directions, no withdrawal period is required before slaughter for human consumption.
Packaging
- Cartons containing 10 X 160-g or 5 X 400-g sachets
Formulation
- Water-soluble granules; concentrated for drinking water or stock solutions.
FDA Status
- Approved by FDA under NADA # 141-336
Accordion Item #1
Lorem Ipsum is simply dummied text of the printing and typesetting industry.
Accordion Item #2
Lorem Ipsum is simply dummied text of the printing and typesetting industry.
Accordion Item #3
Lorem Ipsum is simply dummied text of the printing and typesetting industry.
Available in 400 gram or 160 gram package sizes
Available in the USA
English French Spanish
Fast. Flexible.
Effective.
Get the best results from water medications.
Find strategies
here.
The labeling contains complete use information, including any cautions and warnings. Always read, understand and follow the labeling and use directions. See the reverse side for use directions and additional information.
AIVLOSIN® 17%
(Tylvalosin Type A Medicated Article)
VFD Forms
Product Description
- Aivlosin 17% contains the macrolide antibiotic Tylvalosin and is used for the manufacture of Type B and Type C medicated feeds
- Tylvalosin medicated feed is used for the control of ileitis in swine
- Not to be fed undiluted
- Free-flowing granules
- 50-lb bags
Key Features
- Broad spectrum, potent macrolide not used in human health
- Reliable dosing, consistent mixing
- No withdrawal period (0 days)
- Wide safety margin
Label Indications and Dosage
Caution: Federal law restricts medicated article containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
For Swine: Control of porcine proliferative enteropathy (PPE) associated with Lawsonia intracellularis infection in groups of swine in buildings experiencing an outbreak of PPE.
Feeding Directions: Feed Type C medicated article containing 38.6 grams tylvalosin/ton as the sole ration for 14 consecutive days.
Caution: To assure both food safety and responsible use in swine, concurrent use of tylvalosin Type A medicated article in medicated article and tylvalosin or another macrolide in medicated drinking water or by any other route of administration should be avoided. Not for use in swine intended for breeding. The effects of tylvalosin on swine reproductive performance, pregnancy, and lactation have not been determined. VFDs for tylvalosin shall not be refilled.
Mixing Directions:
Preparation of Type B medicated feed containing 3,856 grams per ton (4,250 ppm) tylvalosin: Prepare tylvalosin Type B medicated article in mash form only. To manufacture one ton of Type B medicated article containing 3,856 g/ton (4,250 ppm) tylvalosin, mix 50 pounds of Aivlosin ® 17% Type A Medicated Article with 1950 pounds of non-medicated feed.
Preparation of Type C medicated feed containing 38.6 grams per ton (42.5 ppm) tylvalosin: To manufacture one ton of Type C medicated feed containing 38.6 g/ton (42.5 ppm) tylvalosin, mix 0.5 pound of Aivlosin® 17% Type A Medicated Article with 1999.5 pounds of non-medicated feed. To aid in the even distribution of drug in the finished feed, add the full amount of Aivlosin® 17% Type A Medicated Article into a small portion of the feed and mix. Blend this mixture into the remainder of the feed and mix thoroughly.
Pelleted Type C medicated feeds must bear an expiration date of 30 days after the date of manufacture.
Crumbled Type C medicated feeds must bear an expiration date of 7 days after the date of manufacture.
Antibacterial Warnings: Use of antibacterial drugs in the absence of a susceptible bacterial infection is unlikely to provide benefit to treated animals and may increase the development of drug-resistant bacteria.
User Safety Warnings: Not for use in humans. Keep out of reach of children. May cause skin irritation. Tylvalosin has been shown to cause hypersensitivity reactions in laboratory animals. People with known hypersensitivity to tylvalosin should avoid contact with this product. In case of accidental ingestion or inhalation, seek medical attention. When handling Aivlosin 17% Type A Medicated Article and preparing medicated feeds, avoid direct contact with the eyes and skin. Wear a dust mask, coveralls and impervious gloves when mixing and handling this product. Eye protection is recommended. In case of accidental eye exposure, wash eyes immediately with water and seek medical attention. If wearing contact lenses, immediately rinse the eyes first, then remove contact lenses and continue to rinse the eyes thoroughly and seek medical attention. In case of accidental skin exposure, wash contaminated skin thoroughly.
The Safety Data Sheet contains more detailed occupational safety information.
Withdrawal Period
- No withdrawal period is required before slaughter for human consumption.
- Different withdrawal times may be required for certain export markets.
Packaging
- 50 lb (22.7 kg) bags
Formulation
- Free-flowing granules.
- Formulated for optimal dispersion, segregation, and stability in feed.
FDA Status
- Type A Medicated Article for use in the manufacture of Type B or Type C medicated article for swine.
- Category I drug; does not require a feed mill license.
- Veterinary feed directive required:Federal law restricts medicated article containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
- Approved by FDA under NADA # 141-460
Swine
Caution: Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
For Swine: Control of porcine proliferative enteropathy (PPE) associated with Lawsonia intracellularis infection in groups of swine in buildings experiencing an outbreak of PPE.
Feeding Directions: Feed Type C medicated feed containing 38.6 grams tylvalosin/ton as the sole ration for 14 consecutive days.
Caution: To assure both food safety and responsible use in swine, concurrent use of tylvalosin Type A medicated article in medicated feed and tylvalosin or another macrolide in medicated drinking water or by any other route of administration should be avoided. Not for use in swine intended for breeding. The effects of tylvalosin on swine reproductive performance, pregnancy, and lactation have not been determined. VFDs for tylvalosin shall not be refilled.
Mixing Directions:
Preparation of Type B medicated feed containing 3,856 grams per ton (4,250 ppm) tylvalosin: Prepare tylvalosin Type B medicated feed in mash form only. To manufacture one ton of Type B medicated feed containing 3,856 g/ton (4,250 ppm) tylvalosin, mix 50 pounds of Aivlosin ® 17% Type A Medicated Article with 1950 pounds of non-medicated feed.
Preparation of Type C medicated feed containing 38.6 grams per ton (42.5 ppm) tylvalosin: To manufacture one ton of Type C medicated feed containing 38.6 g/ton (42.5 ppm) tylvalosin, mix 0.5 pound of Aivlosin® 17% Type A Medicated Article with 1999.5 pounds of non-medicated feed. To aid in the even distribution of drug in the finished feed, add the full amount of Aivlosin® 17% Type A Medicated Article into a small portion of the feed and mix. Blend this mixture into the remainder of the feed and mix thoroughly.
Pelleted Type C medicated feeds must bear an expiration date of 30 days after the date of manufacture.
Crumbled Type C medicated feeds must bear an expiration date of 7 days after the date of manufacture.
Antibacterial Warnings: Use of antibacterial drugs in the absence of a susceptible bacterial infection is unlikely to provide benefit to treated animals and may increase the development of drug-resistant bacteria.
User Safety Warnings: Not for use in humans. Keep out of reach of children. May cause skin irritation. Tylvalosin has been shown to cause hypersensitivity reactions in laboratory animals. People with known hypersensitivity to tylvalosin should avoid contact with this product. In case of accidental ingestion or inhalation, seek medical attention. When handling Aivlosin 17% Type A Medicated Article and preparing medicated feeds, avoid direct contact with the eyes and skin. Wear a dust mask, coveralls and impervious gloves when mixing and handling this product. Eye protection is recommended. In case of accidental eye exposure, wash eyes immediately with water and seek medical attention. If wearing contact lenses, immediately rinse the eyes first, then remove contact lenses and continue to rinse the eyes thoroughly and seek medical attention. In case of accidental skin exposure, wash contaminated skin thoroughly.
The Safety Data Sheet contains more detailed occupational safety information.
Swine
Available in the USA
The labeling contains complete use information, including any cautions and warnings. Always read, understand and follow the labeling and use directions. See the reverse side for use directions and additional information.
[vc_row content_placement=”top” css=”.vc_custom_1513372836541{margin-top: 0px !important;padding-top: 0px !important;}”][vc_column width=”1/2″][vc_column_text]
Aivlosin 0.425%
(Tylvalosin Type B Medicated Feed)
[/vc_column_text][vc_row_inner css=”.vc_custom_1516639645105{margin-bottom: 0px !important;padding-bottom: 0px !important;}”][vc_column_inner][vc_single_image image=”619″ img_size=”full” css=”.vc_custom_1521038185271{margin-top: 0px !important;margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”][/vc_column_inner][/vc_row_inner][vc_tta_accordion c_icon=”” active_section=”0″ collapsible_all=”true”][vc_tta_section i_icon_fontawesome=”fa fa-download” add_icon=”true” title=”VFD Forms” tab_id=”1513633292637-6e5ca99b-4091″][vc_btn title=”Swine” style=”custom” custom_background=”#327ba3″ custom_text=”#ffffff” align=”left” i_icon_fontawesome=”fa fa-download” button_block=”true” add_icon=”true” link=”url:http%3A%2F%2Fpharmgate.com/usa%2Fwp-content%2Fuploads%2F2018%2F03%2FAivlosin-17-VFD-Form-USA-2016.pdf||target:%20_blank|”][/vc_tta_section][/vc_tta_accordion][vc_row_inner css=”.vc_custom_1513716818578{margin-bottom: 0px !important;padding-bottom: 0px !important;}”][vc_column_inner width=”1/2″ offset=”vc_hidden-lg vc_hidden-md vc_hidden-sm vc_hidden-xs”][vc_btn title=”Product Profile” style=”custom” custom_background=”#327ba3″ custom_text=”#ffffff” align=”center” i_icon_fontawesome=”fa fa-download” add_icon=”true” link=”url:http%3A%2F%2Fpharmgate.com/usa%2Fwp-content%2Fuploads%2F2018%2F03%2FAivlosin-Type-B-w-bag-Product-Sheet-2016.pdf||target:%20_blank|”][/vc_column_inner][vc_column_inner width=”1/2″][vc_btn title=”Safety Data Sheet” style=”custom” custom_background=”#327ba3″ custom_text=”#ffffff” align=”center” i_icon_fontawesome=”fa fa-download” add_icon=”true” link=”url:http%3A%2F%2Fpharmgate.com/usa%2Fwp-content%2Fuploads%2F2018%2F05%2FAivlosin_0_425_Tylvalosin_Type_B_Medicated_Feed_3_US_EN_sds.pdf||target:%20_blank|”][/vc_column_inner][/vc_row_inner][vc_tta_accordion active_section=”0″ collapsible_all=”true” css=”.vc_custom_1513632528790{margin-top: 0px !important;padding-top: 0px !important;}”][vc_tta_section title=”Product Description” tab_id=”1513201865211-a42523b6-7183″][vc_column_text]
- Aivlosin 0.425% contains the macrolide antibiotic Tylvalosin and is used for the manufacture of Type C medicated feed
- Not to be fed undiluted
- Tylvalosin medicated feed is used for the control of ileitis in swine
- Veterinary Feed Directive (VFD) required
- 40-lb bags
[/vc_column_text][/vc_tta_section][vc_tta_section title=”Key Features” tab_id=”1513792168267-b1150847-969c”][vc_column_text]
- Available for pigs as an in-feed medication for ileitis control
- Broad spectrum, potent macrolide not used in human health
- Reliable dosing, consistent mixing
- No withdrawal period (0 days)
- Wide safety margin
[/vc_column_text][/vc_tta_section][vc_tta_section title=”Label Indications and Dosage” tab_id=”1513716844386-780f8db5-df08″][ultimate_exp_section title=”Swine” text_color=”#0a0a0a” background_color=”rgba(255,255,255,0.01)” bghovercolor=”rgba(0,0,0,0.01)” title_active_bg=”rgba(244,244,244,0.01)” cnt_bg_color=”rgba(255,255,255,0.01)” icon=”Defaults-plus” new_icon=”Defaults-minus” icon_align=”left” icon_size=”15″ title_alignment=”left” title_margin=”margin:0px;” title_padding=”padding:0px;”][vc_column_text css=”.vc_custom_1528996169509{margin-top: 0px !important;margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”]CAUTION: Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
For Swine: Control of porcine proliferative enteropathy (PPE) associated with Lawsonia intracellularis infection in groups of swine in buildings experiencing an outbreak of PPE.
Feeding Directions: Feed the resulting Type C medicated feed containing 38.6 grams tylvalosin/ton as the sole ration for 14 consecutive days.
CAUTION: To assure both food safety and responsible use in swine, concurrent use of tylvalosin Type A medicated article in medicated feed and tylvalosin or another macrolide in medicated drinking water or by any other route of administration should be avoided. Not for use in swine intended for breeding. The effects of tylvalosin on swine reproductive performance, pregnancy, and lactation have not been determined. VFDs for tylvalosin shall not be refilled.
Mixing Directions: To prepare one ton of complete Type C medicated feed containing 38.6 grams per ton (42.5 ppm) tylvalosin, thoroughly mix 20 pounds of this medicated feed with 1980 pounds of non-medicated feed.
Pelleted Type C medicated feeds must bear an expiration date of 30 days after the date of manufacture.
Crumbled Type C medicated feeds must bear an expiration date of 7 days after the date of manufacture.
ANTIBACTERIAL WARNINGS: Use of antibacterial drugs in the absence of a susceptible bacterial infection is unlikely to provide benefit to treated animals and may increase the development of drug-resistant bacteria.
USER SAFETY WARNINGS: Not for use in humans. Keep out of reach of children. May cause skin irritation. Tylvalosin has been known to cause hypersensitivity reactions in laboratory animals. People with known hypersensitivity to tylvalosin should avoid contact with this product. In case of accidental ingestion, seek medical attention.
[/vc_column_text][/ultimate_exp_section][/vc_tta_section][vc_tta_section title=”Withdrawal Period” tab_id=”1513264661363-6748f0e1-b32e”][vc_column_text]
- No withdrawal period is required before slaughter for human consumption.
- Different withdrawal times may be required for certain export markets.
[/vc_column_text][/vc_tta_section][vc_tta_section title=”Packaging” tab_id=”1513264908146-ea47139b-48ba”][vc_column_text]
- Net weight 40 lb (18.1 kg) Bag.
[/vc_column_text][/vc_tta_section][vc_tta_section title=”Formulation” tab_id=”1513201865229-293b2c0c-7650″][vc_column_text]
- Free-flowing granules.
- Formulated for optimal dispersion, segregation, and stability in feed.
- Contains 17%-20.4% calcium.
[/vc_column_text][/vc_tta_section][vc_tta_section title=”FDA Status” tab_id=”1513264540963-07a4ed72-a0a9″][vc_column_text]
- Type B medicated feed for use in the manufacture of Type C medicated feeds for swine.
- Category I drug; does not require a feed mill license.
- Veterinary feed directive required: Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.
[/vc_column_text][/vc_tta_section][vc_tta_section title=”Storage” tab_id=”1521570256501-4639e8e0-6805″][vc_column_text]Store in a cool dry place at or below 77ºF (25ºC).[/vc_column_text][/vc_tta_section][/vc_tta_accordion][/vc_column][vc_column width=”1/2″][vc_single_image image=”1470″ img_size=”full” alignment=”center” css=”.vc_custom_1521038699606{margin-bottom: 0px !important;padding-bottom: 0px !important;}”][vc_row_inner css=”.vc_custom_1513632376535{margin-top: 0px !important;margin-bottom: 0px !important;padding-top: 0px !important;padding-bottom: 0px !important;}”][vc_column_inner width=”1/3″][/vc_column_inner][vc_column_inner width=”1/3″][vc_column_text]
Available in the USA
[/vc_column_text][/vc_column_inner][vc_column_inner width=”1/3″][/vc_column_inner][/vc_row_inner][/vc_column][/vc_row][vc_row][vc_column][vc_column_text]
The labeling contains complete use information, including any cautions and warnings. Always read, understand and follow the labeling and use directions. See the reverse side for use directions and additional information.
[/vc_column_text][/vc_column][/vc_row]
[/vc_column_text][/vc_column][/vc_row]
